Notable developments catching our attention this week: 1. Ossio raised $27MM in growth capital to support continued commercialization efforts for its resorbable bio-integrative orthopedic fixation technology. 2. Orthocell successfully completed a pre-clinical study in a nerve regeneration model which will support a forthcoming 510(k) submission for its nerve repair product, Remplir. 3. Paradigm Biopharma announced plans to initiate a pivotal Phase 3 clinical trial for its knee OA product, Zilosul, in the first quarter of 2025. How can BCVG help you make sense of the market? Direct message us with to learn more! #Ossio #Orthocell #Zilosul #regenerativemedicine #BCVG
Bruder Consulting & Venture Group’s Post
More Relevant Posts
-
Department Chair | Clinical Professor | Editor-in-Chief | Educator | Speaker | Mentor
Learn about the future of biologic augmentation in The Journal of Orthopaedic Experience & Innovation! Our expert panel discusses the latest in collagen-based grafts, from clinical outcomes to cost considerations. Get insights into reducing reactions, enhancing repairs, and the evolving role of biologics in shoulder and hand surgeries. Catch the full discussion and more on our posted “Open Mic” sessions—visit our site for the latest updates and exclusive content! #JOEI
Biointegrative Collagen Augmentation: Exploring the Vast Array of Orthopedic Indications
https://www.youtube.com/
-
In case you missed it, we recently achieved another milestone with FDA clearance for expanded indications of our NovaBone Putty in interbody fusion applications. This advancement allows our bioactive synthetic bone graft to be used in the intervertebral disc space, enhancing its role in supporting various spinal and orthopedic surgical needs. Learn more: https://lnkd.in/eH_G7R79 #InterbodyFusion #SyntheticBone #MedicalSolutions
-
-
VIA DBM Sponge and VIA DBM Strip are demineralized cancellous sponges and strips intended for use in a variety of different spine and orthopedic bone grafting applications, including intervertebral cages, posterolateral fusion, arthrodesis, and fracture sites. Learn more at VIVEX.com #VIVEXBiologics #VIVEX #VIADBMSponge #VIADBMStrip
-
-
Learn about the future of biologic augmentation in orthopaedics! Our expert panel discusses the latest in collagen-based grafts, from clinical outcomes to cost considerations. Get insights into reducing reactions, enhancing repairs, and the evolving role of biologics in shoulder and hand surgeries. Catch the full discussion and more on our posted “Open Mic” sessions—visit our site for the latest updates and exclusive content! #JOEI
Biointegrative Collagen Augmentation: Exploring the Vast Array of Orthopedic Indications
https://www.youtube.com/
-
VIA DBM Sponge and VIA DBM Strip are demineralized cancellous sponges and strips intended for use in a variety of different spine and orthopedic bone grafting applications, including intervertebral cages, posterolateral fusion, arthrodesis, and fracture sites. Learn more at VIVEX.com #VIVEXBiologics #VIVEX #VIADBMSponge #VIADBMStrip
-
-
Which orthopedic companies are on the rise? Which are moving the other direction? Take a look at the top ten suppliers of orthopedic implants, instruments and other services. https://lnkd.in/dAxA_E8 Pacira BioSciences, Inc. Integra LifeSciences Globus Medical Orthofix Bioventus Zimmer Biomet CONMED Corporation Medtronic axogen Alphatec Spine #PaciraBiosciences #IntegraLifeSciences #GlobusMedical #Orthofix #Bioventus #ZimmerBiomet #ConMed #Medtronic #Axogen #Alphatec
-
-
d-[5-11C]-Glutamine Positron Emission Tomography Imaging for Diagnosis and Therapeutic Monitoring of Orthopedic Implant Infections We are pleased to share this recent article by Cynthia Co, Aditi Mulgaonkar, Ning Zhou, Tam P. Nguyen, Shelby A. Harris, Amber Sherwood, Vicki Ea, Katie Rubitschung, Laila Castellino, Orhan Oz, Xiankai Sun and Liping Tang using #Mediso nanoScan® PET/CT system. https://lnkd.in/dAQnT5Z3 #imaging #preclinicalimaging #molecularimaging
-
-
Ph.D. in Medicine (Orthopaedic Surgery and Mechanical Engineering) | CEO and Co-founder Lifespans, the makers of Alfonso™: The future of implant testing
Why is it dangerous to cut R&D investment at an orthopedic implant company? This month we'll examine this question from multiple perspectives, including a poll, article, and an interactive webinar hosted by myself and my colleagues at Lifespans.
-
-
This post highlights an essential, yet often overlooked, source of back pain—SI joint dysfunction following lumbar fusion. It's incredible to see how Sacrix SIJ fusion offers a solution through such a minimally invasive approach. A less-than-1-inch incision with significant pain relief is a perfect example of the impact the LESS (Less Exposure Spine Surgery) philosophy is having on patient outcomes. The biomechanics of the spine are delicate, and fusions can sometimes shift the load to the SI joint, leading to dysfunction. It's encouraging to witness how innovative techniques like Sacrix are reshaping spine care by providing effective, minimally invasive solutions for these complex cases. Honored to be part of this movement with NANISX, working alongside surgeons who prioritize patient outcomes and better, safer care. www.nanisx.com If you would like to know more, feel free to contact me at mattl@lazzenterprises.com #LESS #Sacrix #SIJ #BackPain #MinimallyInvasive #SpineSurgery #Innovation #PatientOutcomes Kingsley R. Chin MD MBA, CEO Spine Surgeon Professor Author Jonathan Daitch Martin Ferrillo Arthur S.
KIC Ventures Accenture NYC Harvard Medical Sch Harvard Business Sch Harvard Orthopedics Columbia College & Engineering UPenn Former Chief Spine Surgeon
Your Back Pain Could Be Sacroiliac Lumbar fusion can predispose patients to SI joint dysfunction by altering the biomechanics of the SI joint. In this case, a patient reported debilitating back and hip pain after multiple-level lumbar fusions. After diagnosing the SIJ as the source of the pain, the orthopedic spine surgeon performed Sacrix SIJ fusion through a less than 1-inch incision. The patient reported significantly improved outcomes. #BackPain #SIJ #SpineSurgery #SacroiliacFusion #LESS #PatientOutcomes Learn More: www.KICVentures.com www.NANISX.com NANISX KIC Ventures FacetFuse Sacrix NanoFUSE Biologics Inspan Sagitechnology LESS Spine MISquito AxioMed This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.
-
KIC Ventures Accenture NYC Harvard Medical Sch Harvard Business Sch Harvard Orthopedics Columbia College & Engineering UPenn Former Chief Spine Surgeon
Your Back Pain Could Be Sacroiliac Lumbar fusion can predispose patients to SI joint dysfunction by altering the biomechanics of the SI joint. In this case, a patient reported debilitating back and hip pain after multiple-level lumbar fusions. After diagnosing the SIJ as the source of the pain, the orthopedic spine surgeon performed Sacrix SIJ fusion through a less than 1-inch incision. The patient reported significantly improved outcomes. #BackPain #SIJ #SpineSurgery #SacroiliacFusion #LESS #PatientOutcomes Learn More: www.KICVentures.com www.NANISX.com NANISX KIC Ventures FacetFuse Sacrix NanoFUSE Biologics Inspan Sagitechnology LESS Spine MISquito AxioMed This post is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.
